Xtx Topco LTD Stoke Therapeutics, Inc. Transaction History

Xtx Topco LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$4.12 - $14.17 $67,188 - $231,084	16,308 New	16,308 $220,000
Q3 2022 Nov 14, 2022	BUY	$12.56 - $22.53 $139,855 - $250,871	11,135 New	11,135 $143,000
Q3 2021 Nov 12, 2021	SELL	$23.65 - $34.44 $151,880 - $221,173	-6,422 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$30.53 - $41.09 $196,063 - $263,879	6,422 New	6,422 $216,000

125

57.6M

9.3K

35.2K

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $367M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.